Motley Fool July 25, 2021
Despite a lot of noise around the stock, the company has a few paths to grow much larger than it is now.
Key Points
- A change in Medicare quality scoring could mean millions for the company.
- Clover just entered a pilot program that should help it demonstrate its advantage.
- The company’s technology is helping it scale quickly in multiple care settings.
Clover Health (NASDAQ:CLOV) has been on the radar of the meme stock crowd lately. Shares have a high short interest and have been the target of a recent short seller report. They are also down 50% since coming public through Chamath Palihapitiya’s SPAC in January.
Today's Sponsors
Today's Sponsor